Clinical Trial Update: A Study to Learn About a Clostridioides Difficile Vaccine in People 65 Years of Age and Older [Phase 3]

View source ↗

Summary

Pfizer is conducting a Phase 3 clinical trial to evaluate a Clostridioides difficile vaccine in adults 65 years and older with Clostridioides difficile infectio…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Clostridioides Difficile Infection

Drugs mentioned

• Pfizer Clostridioides difficile vaccine

Snippet

Sponsor: Pfizer | Conditions: Clostridioides Difficile Associated Disease | Phase 3 | Status: RECRUITING